Faculty Bibliography

Two hundred years after a vaccine was first used to stem the spread of smallpox, WHO has decided to destroy the last remaining stocks of the smallpox virus, one of the biggest killers in history. Destruction is scheduled for Jun 30, 1999, according to a plan that representatives of 190 counties approved at the final day of the weeklong annual meeting of the health organization

Smallpox remains the only naturally occurring disease ever wiped out of the human population. Destruction of the smallpox virus, known as variola, would be the last step in the smallpox eradication program and the first deliberate extinction of a species. Since 1986, committees of virologists appointed by WHO have recommended destroying the virus after scientists determined what makes up the complete genetic blueprint of at least one strain of the smallpox virus

Two hundred years after a vaccine was first used to stem the spread of smallpox, the World Health Organization has decided to destroy the last remaining stocks of the smallpox virus, one of the biggest killers in history. Destruction is scheduled for June 30, 1999, according to a plan that representatives of 190 counties approved on the final day of the weeklong annual meeting of the health organization. Final approval is required by member countries of WHO, the United Nations agency in Geneva, at their May 1999 meeting. Destruction of the smallpox virus, known as variola, would be the last step in the smallpox eradication program and the first deliberate extinction of a species

Former Sen Paul E. Tsongas of Massachusetts was discharged from a hospital in Boston on May 20, 1996 where he underwent a bone marrow transplant for a complication of the cancer therapy he has received intermittently for a decade, the hospital said. Officials of Dana-Farber Cancer Institute, where the transplant was performed on May 1, said the new 'marrow appears to be growing well.' Tsongas received his transplanted marrow from his twin sister

New York Yankee David Cone underwent a three-hour operation May 10, 1996 to repair an aneurysm in the shoulder region of his throwing arm. The doctors and the Yankees said the operation was successful and that they expected the right-hander to able to return to the mound, but they refused to discuss when Cone might be back, and they abruptly ended the brief news conference at Yankee Stadium when reporters asked questions about the surgery

David Cone, the Yankees' 33-year-old star pitcher, is suffering from complications of a rare type of aneurysm in an artery in his right armpit that developed from the motion he used to deliver countless pitches during his career, according to a doctor familiar with his case. Blood clots that formed in the aneurysm near the shoulder apparently broke off and blocked blood flow, causing tingling and pain in his fingers and making his ring finger turn white. Treatment apparently has alleviated the potentially dangerous problem in Cone's fingers. But the prime problem - the aneurysm in his arm - remains and might require surgery. Officials of Columbia-Presbyterian Medical Center in New York City, where Cone has been treated, have refused to discuss his case. The Yankees were unclear about the medical plans for Cone, saying that additional opinions were being gathered from doctors

New York Yankees pitcher David Cone is suffering from complications of a rare type of aneurysm in an artery in his right armpit that developed from the motion he used to deliver countless pitches during his career, according to a doctor familiar with the case. It is not clear whether Cone will be able to return to the Yankees, but two other pitchers on minor league teams who developed similar aneurysms had the problem corrected surgically and one of them has resumed playing professional baseball

The breast cancer death rate for American women has dropped 5 percent, continuing a decline, but blacks still have a higher death rate than whites, federal health officials said Tuesday. The rate of increase in the death rate for black women slowed, however, compared with the previous decade, said Dr. Robert E. Tarone, an official of the National Cancer Institute. The overall death rate for this type of cancer in American women dropped to 25.9 per 100,000 women in 1993 from 27.5 per 100,000 in 1989. The median age at death for white breast cancer patients is 68 years and for blacks 62 years

The breast cancer death rate for American women has dropped 5%, continuing a decline, but blacks still have a higher death rate than whites, federal health officials said on May 7, 1996. The overall death rate for breast cancer dropped to 25.9 per 100,000 women in 1993 from 27.5 per 100,000 in 1989